Global Interventional Cardiology Devices Market Overview
Introduction:
Interventional cardiology may be a branch of cardiology that deals specifically with the catheter based treatment of structural heart diseases. Many procedures are often performed on the guts by catheterization. This most ordinarily involves the insertion of a sheath into the arteria femoralis (but, in practice, any large peripheral artery or vein) and cannulating the guts under X-ray visualization (most commonly fluoroscopy). The arteria radialis can also be used for cannulation; this approach offers several advantages, including the accessibility of the artery in most patients, the straightforward control of bleeding even in anticoagulated patients, the enhancement of comfort because patients are capable of sitting up and walking immediately following the procedure, and therefore the near absence of clinically significant sequelae in patients with a traditional Allen test. Downsides to the present approach include spasm of the artery and pain, inability to use larger catheters needed in some procedures, and more radiation exposure. The Global Interventional Cardiology Devices Market accounted for US$ 5.50 billion in 2020 and is estimated to be US$ 11.31 billion by 2030 and is anticipated to register a CAGR of 7.50%.
Global Interventional Cardiology Devices Market Dynamics
Increasing prevalence of Non-Communicable disease
The dominance of non-communicable diseases has increased due to unhealthy lifestyle habits, like consumption of excess salt, saturated fats, and sugars, lack of physical activities, high tobacco, and alcohol consumption. Rising prevalence of lifestyle habits like a growing number of smokers, rising incidence rates of obesity, and dietary irregularities are liable for the expansion within the prevalence of major cardiovascular diseases across the planet fuelling interventional cardiology device industry growth. Each year, 170,000 people die from heart and circulatory diseases within the UK. Such a huge patient population and therefore the high death rate is predicted to extend the demand for interventional cardiology devices within the coming years.
Rising number of diabetic patients
Risk factors, like diabetes and hypertension, also fuel the demand for interventional cardiology devices. People with diabetes are more likely to possess other conditions that raise the danger of coronary heart condition. Over time, high blood glucose can damage the blood vessels that control the guts.
Global Interventional Cardiology Devices Market Segmentation
The global interventional cardiology devices market report segments the market on the basis of type and region.
On the basis of type, the global market is sub-divided into Angioplasty Balloons, Angioplasty Stents, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, and Other.
Regional Insights:
For detailed understanding of market dynamics, On the basis of region, the Global Interventional Cardiology Devices Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America accounted for the largest share of the interventional cardiology devices market. The large share of North America can be attributed to factors such as the increasing prevalence of diabetes, rising aging population, availability of reimbursement, and the presence of all key players.
|
Attribute |
Details |
|
Base year for estimation |
2020 |
|
Forecast period |
2020 – 2030 |
|
Market representation |
Revenue in USD Million & CAGR from 2020 – 2030 |
|
Market Segmentation |
By Type: Angioplasty Balloons, Angioplasty Stents, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, and Other |
|
Regional scope |
North America - U.S., Canada Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific Latin America - Brazil, Mexico, Argentina, Rest of Latin America Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa |
|
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors, and trends |
Detailed Segmentation:
Global Interventional Cardiology Devices Market, By Region, 2019 – 2029, (US$ Mn)
-
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2019 — 2029
- Y-o-Y Growth Analysis (%), 2019 – 2029
- Regional Trends
- North America
- Market Size and Forecast (US$ Mn), By Types, 2019 – 2029
- Market Size and Forecast (US$ Mn), By Country, 2019 – 2029
- U.S.
- Canada
- Europe
- Market Size and Forecast (US$ Mn), By Types, 2019 – 2029
- Market Size and Forecast (US$ Mn), By Country, 2019 – 2029
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia Pacific
- Market Size and Forecast (US$ Mn), By Types, 2019 – 2029
- Market Size and Forecast (US$ Mn), By Country, 2019 – 2029
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
- Latin America
- Market Size and Forecast (US$ Mn), By Types, 2019 – 2029
- Market Size and Forecast (US$ Mn), By Country, 2019 – 2029
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- Market Size and Forecast (US$ Mn), By Types, 2019 – 2029
- Market Size and Forecast (US$ Mn), By Country, 2019 – 2029
- GCC
- Israel
- South Africa
- Rest of Middle East
- Overview
Global Interventional Cardiology Devices Market Key Players
The Key players in the global interventional cardiology devices market includes, Cordis Corporation, Abbott Laboratories, Medtronic, Inc., Terumo Medical Corporation, Braun Melsungen AG, Boston Scientific Coprporation, Terumo Corporation, Cordis Corporation, Biosensors International Group, Ltd., and Biotronik, Inc.
Global Interventional Cardiology Devices Market Company Profile
-
-
- Cordis Corporation
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Abbott Laboratories
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Medtronic, Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Terumo Medical Corporation
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Braun Melsungen AG
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Boston Scientific Coprporation
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Terumo Corporation
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Cordis Corporation
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Biosensors International Group, Ltd.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Biotronik, Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Cordis Corporation
-
Global Interventional Cardiology Devices Market Table of Contents
- Research Objective and Assumption
- Preface
- Research Objectives
- Study Scope
- Years Considered for the study
- Assumptions
- Abbreviations
- Research Methodology
- Research data
- Primary Data
- Primary Interviews
- Primary Breakdown
- Key data from Primary Sources
- Key Thickness Insights
- Secondary Data
- Major Secondary Sources
- Secondary Sources
- Market Estimation
- Top-Down Approach
- Approach for estimating Market Share by Top-Down Analysis (Supply Side)
- Bottom-Up Approach
- Approach for estimating market share by Bottom-up Analysis (Demand Side)
- Market Breakdown and Data Triangulation
- Research Assumptions
- Market Purview
- Executive Summary
- Key Findings—Global Outlook for Interventional Cardiology Devices Strategies
- Key Questions this Study will Answer
- Market Snippet, By Type
- Market Snippet, By Region
- Opportunity Map Analysis
- Executive Summary—3 Big Predictions
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Market Trends
- DR Impact Analysis
- PEST Analysis
- Porter’s Five Forces Analysis
- Opportunity Orbit
- Market Investment Feasibility Index
- Macroeconomic Factor Analysis
- Market Dynamics
- Global Interventional Cardiology Devices Market, By Type, 2020 – 2030, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Segment Trends
- Angioplasty Balloons
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Angioplasty Stents
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Catheters
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Plaque Modification Devices
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Hemodynamic Flow Alteration Devices
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Others
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Overview
- Global Interventional Cardiology Devices Market, By Region, 2020 – 2030, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Regional Trends
- North America
- Market Size and Forecast (US$ Mn), By Type, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- U.S.
- Canada
- Europe
- Market Size and Forecast (US$ Mn), By Type, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- UK
- France
- Germany
- Russia
- Italy
- Rest of Europe
- Asia Pacific
- Market Size and Forecast (US$ Mn), By Type, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
-
- India
- Japan
- South Korea
- China
- Rest of Asia Pacific
- Latin America
- Market Size and Forecast (US$ Mn), By Type, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- Market Size and Forecast (US$ Mn), By Type, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- GCC
- Israel
- South Africa
- Rest of Middle East
- Overview
- Competitive Landscape
- Heat Map Analysis
- Market Presence and Specificity Analysis
- Company Profiles
-
- Cordis Corporation
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Abbott Laboratories
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Medtronic, Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Terumo Medical Corporation
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Braun Melsungen AG
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Boston Scientific Coprporation
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Terumo Corporation
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Cordis Corporation
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Biosensors International Group, Ltd.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Biotronik, Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Cordis Corporation
-
The Last Word
-
- Future Impact
- About Us
- Contact
FAQs
Global Interventional Cardiology Devices Market is segmented on the basis of type, and region.
Prevalence of major cardiovascular diseases across the planet fuelling interventional cardiology device industry growth.
North America is estimated to hold dominating position in the Global Interventional Cardiology Devices Market during the forecast period.
The Key players in the global interventional cardiology devices market includes, Cordis Corporation, Abbott Laboratories, Medtronic, Inc., Terumo Medical Corporation, Braun Melsungen AG, Boston Scientific Coprporation, Terumo Corporation, Cordis Corporation, Biosensors International Group, Ltd., and Biotronik, Inc.